FEATURES AND PROGNOSTIC FACTORS TO THE SEVERITY OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) AT CAN THO CHILDREN’S HOSPITAL IN 2021-2022
Main Article Content
Abstract
Background: Multisystem inflammatory syndrome in children (MIS-C) is a newly identified and serious health condition associated with SARS-CoV-2 infection. Clinical manifestational varies widely among patients with MIS-C and factors associated with severe outcomes. Objective: 1) To describe the clinical and paraclinical characteristics, treatment results in children with MIS-C. 2) To identify prognostic factors to the severity of MIS-C. Materials and methods: An analytic crosssectional study of 61 cases of MIS-C in Can Tho Children’s Hospital. Results: The median age was 45.0 (22.5-108.0) months, with a male-to-female ratio of 2:1. The median time from SARS-CoV-2 infection to MIS-C onset was 4.5 (4.0-7.5) weeks. Clinical symptoms included high fever (89.5%), gastrointestinal symptoms (75.4%), and conjunctivitis (82.5%). The number of severe cases is 16 (26.2%), with severe deterioration after 24 hours of hospital admission being 12 (19.7%). Paraclinical characteristics included CRP >10 mg/L (96.1%), fibrinogen >4.5 g/L (71.7%). All cases were cured and discharged from the hospital. Independent factors associated with the severity of disease are: abdominal pain OR=10.984 (95% CI: 1.602-75.294, p=0.015), elevated ferritin OR=4.689 (95% CI: 1.015-21.664, p=0.048), elevated D-dimer OR=7.694 (95% CI: 1.537-38.507, p=0.013), elevated troponin I OR=6.657 (95% CI: 1.124-39.431, p=0.037). Conclusion: Children with MIS-C are mainly males with a median age of 45.0 (22.5-108.0) months, common symptoms include Kawasaki-like skin lesions and gastrointestinal symptoms. Severe cases account for 26.2%, with deterioration after 24 hours of hospitalization accounting for 19.7%. Abdominal pain, elevated ferritin, elevated D-dimer, and elevated troponin-I are independent and prognostic factors for the severity of MIS-C after 24 hours of hospitalization.
Article Details
Keywords
MIS-C, prognostic factors, severity
References
2. Feldstein L. R., Rose E. B., Horwitz S. M., Collins J. P., Newhams M. M., et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020. 383 (4), 334346, doi: 10.1056/NEJMoa2021680.
3. Godfred-Cato S., Bryant B., Leung J., Oster M. E., Conklin L., et al. COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 2020. 69 (32), 1074-1080, doi: 10.15585/mmwr.mm6932e2.
4. Bộ Y tế. Quyết định số 405/QĐ-BYT ngày 22 tháng 2 năm 2022. Hướng dẫn chẩn đoán và điều trị COVID-19 ở trẻ em. 2022: 44-47.
5. Phung Nguyen The Nguyen, Tran Thanh Thuc, Nguyen Thanh Hung, Nguyen Tri Hao, va Nguyen Thi Mai Thao. Cardiovascular injury and clinical features of multisystem inflammatory syndrome in children (MIS-C) related to Covid-19 in Vietnam. 2022. 63 (6), 569-574, doi: 10.1016/j.pedneo.2022.05.009.
6. Jinna S., and Khandhar PB. Thrombocytopenia. StatPearls. 2023.
7. Lanziotti V. S., Povoa P., Soares M., Silva J. R., Barbosa A. P., et al. Use of biomarkers in pediatric sepsis: literature review. Rev Bras Ter Intensiva. 2016. 28 (4), 472-482, doi: 10.5935/0103-507X.20160080.
8. Dufort E. M., Koumans E. H., Chow E. J., Rosenthal E. M., Muse A., et al. Multisystem Inflammatory Syndrome in Children in New York State. N Engl J Med. 2020. 383 (4), 347-358, doi: 10.1056/NEJMoa2021756.
9. Kaushik A., Gupta S., Sood M., Sharma S., and Verma S. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection. Pediatr Infect Dis J. 2020. 39 (11), 340-346, doi: 10.1097/INF.0000000000002888.
10. Capone Christine A, Subramony Anupama, Sweberg Todd, Schneider James, Shah Sareen, et al. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory syndrome of childhood associated with severe acute respiratory syndrome coronavirus 2 infection. 2020. 224 141-145, doi: 10.1016/j.jpeds.2020.06.044.
11. Valverde I., Singh Y., Sanchez-de-Toledo J., Theocharis P., Chikermane A., et al. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe. Circulation. 2021. 143 (1), 21-32, doi: 10.1161/CIRCULATIONAHA.120.050065.
12. Abrams J. Y., Oster M. E., Godfred-Cato S. E., Bryant B., Datta S. D., et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health. 2021. 5 (5), 323-331, doi:
10.1016/S2352-4642(21)00050-X.